JUDY NEWMAN jdnewman@madison.com Dec 2, 2018 CEO Roland Green, left, talks with scientist Daniel Gerhardt at Invenra’s labs, 505 S. Rosa Road, where researchers are developing cancer-fighting drugs. Green majored in English literature then switched to...
SHINE and Deerfield Close $150 Million Financing SHINE AND DEERFIELD CLOSE $150 MILLION FINANCING COMMITMENT TO SUPPORT DIAGNOSTIC AND THERAPEUTIC MEDICAL ISOTOPE MANUFACTURING November 27, 2018 – New York, NY and Janesville, WI – SHINE Medical Technologies Inc....
JUDY NEWMAN jdnewman@madison.com Nov 25, 2018 Research scientist David Marshall, left, and senior scientist Mike Moser look at cells being grown for studies of an experimental flu vaccine at FluGen. AMBER ARNOLD, STATE JOURNAL ARCHIVES FluGen is just finishing one...
Phoenix Delivers First Production Accelerator SHINE On Path to Become Leading Domestic Producer of Mo-99 Photo: SHINE CEO, Greg Piefer, standing with parts of the Phoenix first production unit accelerator, delivered to SHINE Building One on Monday. October 18th, 2018...
MADISON, Wis. – October 17, 2018 – Invenra, an antibody drug discovery and development company with novel multispecific platforms and product candidates, announced the close of a $7M Series B financing round. The financing will be used to expand the company to meet...
Recent Comments